Clinical Trial Update: Lithium Countertransport and Blood Pressure In CARDIA and TOMHS

View source ↗

Summary

A completed clinical trial update examining lithium countertransport and its relation to blood pressure in the CARDIA and TOMHS cohorts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Disease
• Hypertension

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED